Kazakhstan Country Commercial Guide
Learn about the market conditions, opportunities, regulations, and business conditions in kazakhstan, prepared by at U.S. Embassies worldwide by Commerce Department, State Department and other U.S. agencies’ professionals
Select Country Guide
Healthcare
Last published date:

Overview

Kazakhstan’s healthcare sector accounted for roughly 2.9% of GDP in 2020. Government priorities in this sector include developing the country’s primary healthcare networks, improving its public health administration system, providing expanded medical personnel training, enhancing mother and child health services and emphasizing preventive measures such as diagnostics, treatment of lifestyle diseases, patient rehabilitation and development of personalized medicine. The Kazakhstani government allocated approximately USD 5.4 billion from the 2021 budget to the country’s healthcare sector .

In 2019, the government approved the State Program for the Development of Healthcare 2020-2025.  Target indicators under the program include increasing life expectancy to 75 years; reducing the risk of premature mortality of people 30 to 70 years of age due to cardiovascular, oncological, chronic respiratory diseases and diabetes; reduction of maternal mortality from 15.5 to 14.5 per 100,000 live births and reduction of infant mortality from 9.0 to 8.3 per 1000 live births.  The total budget of the program is estimated at USD 7.5 billion based on 2020 exchange rates. 

Opportunities

The market for medical equipment in Kazakhstan is roughly USD 1.3 billion.  Domestic manufacturing of medical equipment is limited in Kazakhstan, with 90% of equipment imported.  The bulk (85%) of medical equipment in Kazakhstan is purchased by the public sector. Most procurement for public healthcare institutions is done through government-related tenders.  More than 37% of medical equipment currently in use is obsolete and the government recognizes the need to update equipment in use in the country’s public hospitals.

Local producers of medical equipment are unable to fully supply the market with necessary equipment and there are no capabilities to develop a strong local industry in the near term. Currently, there are about 60 companies in Kazakhstan registered as medical equipment producers, most of which are small businesses with insignificant production volumes.

In December 2019, the Kazakhstani government and EBRD signed a Memorandum of Understanding on the implementation of a Comprehensive Program for the Modernization of Healthcare Infrastructure in Kazakhstan (https://www.ebrd.com/documents/procurement/82870-tors.pdf?blobnocache=true).  The program envisages the construction of up to 19 new hospitals to replace 40 outdated existing facilities and the upgrade of up to 50% of the hospital bed capacity in Kazakhstan as part of the State Health Care Development Program for 2020–2024.  Hospital projects under the State Program will follow the facility management model and will be procured as Public Private Partnerships or utilize the Design, Build, Operate and Maintain approach. The hospitals included in this initial first phase of the program include: Kyzylorda, Kokshetau, Kostanai, Taraz, Pavlodar and Atyrau.  In 2020, the EBRD issued a solicitation to identify a consultancy for the development of a comprehensive healthcare needs assessment and functional specifications for these hospitals.

Leading Sub-Sectors

  • electro-medical diagnostic and therapy equipment;
  • diagnostic imaging with a special emphasis on X-ray equipment and supplies;
  • equipment for cardiology and cardio surgery;
  • chemotherapy, mammography, radiotherapy, and computed tomography equipment;
  • neurosurgery equipment; 
  • diabetic supplies;
  • laboratory equipment; 
  • healthcare digitalization and mobile health technologies.

Resources

  • Trade Show: KIHE 2023: Kazakhstan International Healthcare Exhibition, May 17-19, 2023, Almaty, Kazakhstan
  • Trade Show: Astana Zdorovie: International Kazakhstan Exhibition on Healthcare, October 26-28, 2022, Nur-Sultan, Kazakhstan
  • Ministry of Healthcare of the Republic of Kazakhstan (http://kamld.kz/)
  • For more information contact Commercial Specialist Nurlan.Zhangarin@trade.gov

×

Global Business Navigator Chatbot Beta

Welcome to the Global Business Navigator, an artificial intelligence (AI) Chatbot from the International Trade Administration (ITA). This tool, currently in beta version testing, is designed to provide general information on the exporting process and the resources available to assist new and experienced U.S. exporters. The Chatbot, developed using Microsoft’s Azure AI services, is trained on ITA’s export-related content and aims to quickly get users the information they need. The Chatbot is intended to make the benefits of exporting more accessible by understanding non-expert language, idiomatic expressions, and foreign languages.

Limitations

As a beta product, the Chatbot is currently being tested and its responses may occasionally produce inaccurate or incomplete information. The Chatbot is trained to decline out of scope or inappropriate requests. The Chatbot’s knowledge is limited to the public information on the Export Solutions web pages of Trade.gov, which covers a wide range of topics on exporting. While it cannot provide responses specific to a company’s product or a specific foreign market, its reference pages will guide you to other relevant government resources and market research. Always double-check the Chatbot’s responses using the provided references or by visiting the Export Solutions web pages on Trade.gov. Do not use its responses as legal or professional advice. Inaccurate advice from the Chatbot would not be a defense to violating any export rules or regulations.

Privacy

The Chatbot does not collect information about users and does not use the contents of users’ chat history to learn new information. All feedback is anonymous. Please do not enter personally identifiable information (PII), sensitive, or proprietary information into the Chatbot. Your conversations will not be connected to other interactions or accounts with ITA. Conversations with the Chatbot may be reviewed to help ITA improve the tool and address harmful, illegal, or otherwise inappropriate questions.

Translation

The Chatbot supports a wide range of languages. Because the Chatbot is trained in English and responses are translated, you should verify the translation. For example, the Chatbot may have difficulty with acronyms, abbreviations, and nuances in a language other than English.

Privacy Program | Information Quality Guidelines | Accessibility